75 related articles for article (PubMed ID: 24396142)
1. Cytochrome p450 inhibitory properties of common efflux transporter inhibitors.
Englund G; Lundquist P; Skogastierna C; Johansson J; Hoogstraate J; Afzelius L; Andersson TB; Projean D
Drug Metab Dispos; 2014 Mar; 42(3):441-7. PubMed ID: 24396142
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor.
Zhang H; Ou YC; Su D; Wang F; Wang L; Sahasranaman S; Tang Z
Pharmacol Res Perspect; 2021 Dec; 9(6):e00870. PubMed ID: 34664792
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
Chu J; Panfen E; Wang L; Marino A; Chen XQ; Fancher RM; Landage R; Patil O; Desai SD; Shah D; Xue Y; Sinz M; Shen H
Pharm Res; 2023 Nov; 40(11):2567-2584. PubMed ID: 37523014
[TBL] [Abstract][Full Text] [Related]
4. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M
Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203
[TBL] [Abstract][Full Text] [Related]
5. Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s.
Lindmark B; Lundahl A; Kanebratt KP; Andersson TB; Isin EM
Br J Pharmacol; 2018 Jun; 175(11):2116-2129. PubMed ID: 29574682
[TBL] [Abstract][Full Text] [Related]
6. The Differential Absorption of a Series of P-Glycoprotein Substrates in Isolated Perfused Lungs from Mdr1a/1b Genetic Knockout Mice can be Attributed to Distinct Physico-Chemical Properties: an Insight into Predicting Transporter-Mediated, Pulmonary Specific Disposition.
Price DF; Luscombe CN; Eddershaw PJ; Edwards CD; Gumbleton M
Pharm Res; 2017 Dec; 34(12):2498-2516. PubMed ID: 28702798
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?
Guo C; Yang K; Liao M; Xia CQ; Brouwer KR; Brouwer KLR
J Pharm Sci; 2017 Sep; 106(9):2401-2406. PubMed ID: 28465154
[TBL] [Abstract][Full Text] [Related]
8. Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules.
Hamaguchi-Suzuki N; Adachi N; Moriya T; Yasuda S; Kawasaki M; Suzuki K; Ogasawara S; Anzai N; Senda T; Murata T
Biochem Biophys Res Commun; 2024 May; 709():149855. PubMed ID: 38579618
[TBL] [Abstract][Full Text] [Related]
9. Defining Human Pathways of Drug Metabolism In Vivo through the Development of a Multiple Humanized Mouse Model.
Scheer N; Kapelyukh Y; Rode A; Oswald S; Busch D; McLaughlin LA; Lin D; Henderson CJ; Wolf CR
Drug Metab Dispos; 2015 Nov; 43(11):1679-90. PubMed ID: 26265742
[TBL] [Abstract][Full Text] [Related]
10. Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.
Weiss J; Gajek T; Köhler BC; Haefeli WE
Pharmaceutics; 2016 Feb; 8(1):. PubMed ID: 26927160
[TBL] [Abstract][Full Text] [Related]
11. Drug-drug interactions involving classic psychedelics: A systematic review.
Halman A; Kong G; Sarris J; Perkins D
J Psychopharmacol; 2024 Jan; 38(1):3-18. PubMed ID: 37982394
[TBL] [Abstract][Full Text] [Related]
12. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.
Lee JS; Oh Y; Park JH; Kyung SY; Kim HS; Yoon S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430288
[TBL] [Abstract][Full Text] [Related]
13. Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients.
Cheng S; Tang M; Du J; Yin T
Eur J Hosp Pharm; 2022 Jul; 29(4):202-206. PubMed ID: 33020057
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.
Xia T; Zhu S; Wen Y; Gao S; Li M; Tao X; Zhang F; Chen W
Drug Des Devel Ther; 2018; 12():417-428. PubMed ID: 29535503
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes.
Lu Y; Slizgi JR; Brouwer KR; Claire RL; Freeman KM; Pan M; Brock WJ; Brouwer KL
Drug Metab Dispos; 2016 Jun; 44(6):867-70. PubMed ID: 27013400
[TBL] [Abstract][Full Text] [Related]
16. Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging.
Végvári Á; Shavkunov AS; Fehniger TE; Grabau D; Niméus E; Marko-Varga G
Clin Transl Med; 2016 Mar; 5(1):10. PubMed ID: 26965929
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.
Xie JD; Huang Y; Chen DT; Pan JH; Bi BT; Feng KY; Huang W; Zeng WA
PLoS One; 2015; 10(12):e0143701. PubMed ID: 26633878
[TBL] [Abstract][Full Text] [Related]
18. Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models.
MacLeod AK; McLaughlin LA; Henderson CJ; Wolf CR
Cancer Res; 2015 Nov; 75(21):4573-81. PubMed ID: 26363009
[TBL] [Abstract][Full Text] [Related]
19. Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies.
Greenblatt DJ; Harmatz JS
Br J Clin Pharmacol; 2015 Sep; 80(3):342-50. PubMed ID: 25923589
[TBL] [Abstract][Full Text] [Related]
20. Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects.
Pang X; Zhang Y; Gao R; Zhong K; Zhong D; Chen X
Antimicrob Agents Chemother; 2014 Oct; 58(10):5987-93. PubMed ID: 25070100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
